Transatlantic Holdings Inc

Transatlantic — Merger or Acquisition (September 2011)

15 slides from Transatlantic's merger presentation, Sep 1, 2011

  1. Slide 1: Transatlantic Stockholders – Don't be Fooled: AWAC's Valuation Claims

    Slide 1: Transatlantic Stockholders – Don't be Fooled: AWAC's Valuation Claims

    Transatlantic Stockholders – Don’t be Fooled August 2011 AWAC’s Valuation Claims FILED BY VALIDUS HOLDINGS, LTD. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-6 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: TRANSATLANTIC HOLDINGS, INC. COMMI

  2. Slide 2: Cautionary Note Regarding Forward-looking Statements

    Slide 2: Cautionary Note Regarding Forward-looking Statements

    Cautionary Note Regarding Forward-looking Statements This presentation may include forward-looking statements, both with respect to Validus and its industry, that reflect Validus' current views with respect to future events and financial performance. Statements that include the words "expect," "inte

  3. Slide 3: Additional Information, Participants in the Solicitation & Non-GAAP Financial Measures

    Slide 3: Additional Information, Participants in the Solicitation & Non-GAAP Financial Measures

    Additional Information, Participants in the Solicitation & Non-GAAP Financial Measures Additional Information about the Proposed Transaction and Where to Find It: Validus has commenced an exchange offer to acquire all of the outstanding shares of common stock of Transatlantic for 1.5564 Validus voti

  4. Slide 4: Transatlantic Stockholders Shouldn't be Fooled by AWAC's Valuation Claims

    Slide 4: Transatlantic Stockholders Shouldn't be Fooled by AWAC's Valuation Claims

    Transatlantic Stockholders Shouldn’t be Fooled by AWAC’s Valuation Claims 4 The Validus offer delivers greater market value to Transatlantic stockholders Allied World (“AWAC”) recently filed materials with the Securities and Exchange Commission containing what Validus believes are spurious valuation

  5. Slide 5: Superior Market Value for Transatlantic Stockholders

    Slide 5: Superior Market Value for Transatlantic Stockholders

    Validus Validus AWAC Merger Exchange Takeover Proposal Offer Offer Share Price (8/31/11) $25.82 $25.82 $51.90 x Exchange Ratio 1.5564 1.5564 0.8800 Equity Per Transatlantic Share $40.19 $40.19 $45.67 + Pre-Closing Transatlantic Cash Dividend $8.00 - - + Cash - $8.00 - Total Consideration per Transat

  6. Slide 6: Validus Delivers Superior Value to Transatlantic Stockholders

    Slide 6: Validus Delivers Superior Value to Transatlantic Stockholders

    Validus Delivers Superior Value to Transatlantic Stockholders 6 Note: Unaffected data as at 6/10/2011, immediately prior to AWAC/Transatlantic announcement 1 Value delivered based on relevant unaffected counterparty multiple multiplied by pro forma book value delivered per Transatlantic share 2 Valu

  7. Slide 7: Validus Has an Established Record of Trading at a Premium Multiple to AWAC

    Slide 7: Validus Has an Established Record of Trading at a Premium Multiple to AWAC

    Validus Has an Established Record of Trading at a Premium Multiple to AWAC 7 Price / As-Reported Diluted Book Value1 1 Quarterly Price / Diluted Book Value Per Share shown for 1/1/2009 through 7/12/2011 – point value based on book value as of quarter end and share price on day immediately following

  8. Slide 8: Validus Trades at a Premium Multiple to the Peers Attributed to it by AWAC

    Slide 8: Validus Trades at a Premium Multiple to the Peers Attributed to it by AWAC

    8 Price / As-Reported Diluted Book Value1 1 Quarterly Price / Diluted Book Value Per Share shown for 1/1/2009 through 7/12/2011 – point value based on book value as of quarter end and share price on day immediately following release of relevant quarter’s earnings, except for 7/12/2011 2 Validus’ pee

  9. Slide 9: AWAC Has a Record of Trading at a Comparatively Low Multiple

    Slide 9: AWAC Has a Record of Trading at a Comparatively Low Multiple

    AWAC Has an Established Record of Trading at a Comparatively Low Multiple and No Apparent Basis to Assert that it Should Trade like the Specialty P&C “Peer Group” it has Selected 9 Price / As-Reported Diluted Book Value1 1 Quarterly Price / Diluted Book Value Per Share shown for 1/1/2009 through 7/1

  10. Slide 10: AWAC Resorts to Its Undefined, Inconsistent "Intrinsic Value" Concept

    Slide 10: AWAC Resorts to Its Undefined, Inconsistent "Intrinsic Value" Concept

    AWAC Resorts to Its Undefined, Inconsistent “Intrinsic Value” Concept In An Apparent Effort to Mislead Transatlantic Stockholders 10 1 Source: AWAC Form 425 filed 8/29/11. Share prices as of 8/31/11. Source: Company filings, SNL The Marketplace Clearly Places No Credence on AWAC’s “Intrinsic Value”

  11. Slide 11: The Concept of "Intrinsic Value" is Conspicuously Absent from Fairness Opinions

    Slide 11: The Concept of "Intrinsic Value" is Conspicuously Absent from Fairness Opinions

    The Concept of “Intrinsic Value” is Conspicuously Absent from Fairness Opinions 11 Date Announced Transaction Fairness Opinion Provider Methodology Comparable Companies Precedent Transactions Dividend Discount Analysis “Intrinsic Value” Analysis 6/13/2011 Allied World /Transatlantic Moelis (Transatl

  12. Slide 12: Validus' Superior Proposal is Not Subject to a Due Diligence Condition

    Slide 12: Validus' Superior Proposal is Not Subject to a Due Diligence Condition

    Notwithstanding AWAC’s Claims, Validus’ Superior Proposal is Not Subject to a Due Diligence Condition, is Effectively No More Conditional than AWAC’s Takeover and Can be Closed During the Fourth Quarter of 2011 12 1 Not intended to be exhaustive list of conditions 2 Validus filed its Form A with the

  13. Slide 13: Superior Financial Proposal – Higher Quality Currency

    Slide 13: Superior Financial Proposal – Higher Quality Currency

    Superior Financial Proposal – Higher Quality Currency Validus AWAC Market Capitalization 1 $3.0 billion $2.2 billion Superior Liquidity Average Daily Trading Volumes 1 3 month - $27.6 million 6 month - $22.4 million Average Daily Trading Volumes 1 3 month - $14.6 million 6 month - $13.4 million Tota

  14. Slide 14: Appendix: Reconciliation of Non-GAAP Measures

    Slide 14: Appendix: Reconciliation of Non-GAAP Measures

    Appendix Reconciliation of Non-GAAP Measures

  15. Slide 15: Diluted Book Value Per Share Reconciliation

    Slide 15: Diluted Book Value Per Share Reconciliation

    Diluted Book Value Per Share Reconciliation 15 (a) Weighted average exercise price for those warrants and stock options that have an exercise price lower than book value per shares. (b) Using the "as-if-converted" method, assuming all proceeds received upon exercise of warrants and stock options wil

Source: SEC EDGAR · 425 filed Sep 1, 2011

More decks from Transatlantic Holdings Inc